These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 35594413)

  • 1. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.
    Gao K; Wang R; Chen J; Cheng L; Frishcosy J; Huzumi Y; Qiu Y; Schluckbier T; Wei X; Wei GW
    Chem Rev; 2022 Jul; 122(13):11287-11368. PubMed ID: 35594413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic.
    Ma L; Li H; Lan J; Hao X; Liu H; Wang X; Huang Y
    Comput Biol Chem; 2021 Dec; 95():107599. PubMed ID: 34773807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.
    Zhou H; Ni WJ; Huang W; Wang Z; Cai M; Sun YC
    Front Immunol; 2022; 13():834942. PubMed ID: 35450063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host Immune Response Driving SARS-CoV-2 Evolution.
    Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation.
    Nguyen H; Nguyen HL; Lan PD; Thai NQ; Sikora M; Li MS
    Chem Soc Rev; 2023 Sep; 52(18):6497-6553. PubMed ID: 37650302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.
    Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG
    Elife; 2022 Nov; 11():. PubMed ID: 36416537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.
    Selvaraj C; Dinesh DC; Panwar U; Abhirami R; Boura E; Singh SK
    J Biomol Struct Dyn; 2021 Aug; 39(13):4582-4593. PubMed ID: 32567979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Applications of separation technology in novel coronavirus research, epidemic prevention and detection].
    Li L; Zhu C; Zhao X; Qu F
    Se Pu; 2021 Jul; 39(7):679-685. PubMed ID: 34227364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
    Sarkar JP; Saha I; Seal A; Maity D; Maulik U
    Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins.
    Verkhivker GM
    J Proteome Res; 2020 Nov; 19(11):4587-4608. PubMed ID: 33006900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro.
    Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S
    Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of SARS-CoV-2 Virus Proteins: Implications on Its Proteome.
    Sarkar M; Saha S
    Methods Mol Biol; 2023; 2627():265-299. PubMed ID: 36959453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Identification of Anti-SARS-CoV-2 Medicinal Plants Using Cheminformatics and Machine Learning.
    Liang J; Zheng Y; Tong X; Yang N; Dai S
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.